Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Frequency and Factors Associated with Disabilities among Leprosy Patients Admitted to the Kindia Disability Prevention and Physical Rehabilitation Centre (Pirp) in Guinea from 2017 to 2021

Ibrahima Sory SS, Sidikiba S, Delphin K, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2024; 9 (10) : 1-9.
Download PDF
Publication

Burden of leprosy and associated risk factors for disabilities in Tanzania from 2017 to 2020

Mrema G, Hussein A, Magoge W, et al. Public Library of Science (PLoS). PLOS ONE. 2024; 19 (10) : 1-13.
Download PDF
Publication

Erythema nodosum leprosum: condition developed by non-adherence

Gladwin E, Patel M, Mistry M. Innovare Academic Sciences Pvt Ltd. International Journal of Pharmacy and Pharmaceutical Sciences. 2024;
Download PDF
Publication

Reação adversa grave à dapsona no tratamento da hanseníase

Rodrigues MEG, Costa JEFD, Palitot EB. Instituto Lauro de Souza Lima. Hansenologia Internationalis: hanseníase e outras doenças infecciosas. 2024;
Download PDF
Publication

Avaliação do grau de incapacidade neurofuncional dos pacientes com diagnóstico de Hanseníase/ Assessment of the degree of neurofunctional disability in patients diagnosed with leprosy

Oliveira PDS, Silva AMFD, Neto LRDS, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2021; 4 (4) : 15870-15887.
Download PDF
Publication

The First Case Report of Pulmonary Hypertension in Leprosy

Siregar M, Wahidji V. Iranian Heart Journal. 2024;
Download PDF
Publication

Immune-Mediated Glomerulonephritis as Type 2 Lepra Reaction Posttreatment of Lepromatous Leprosy: A Case Report.

Kantak D, Dsouza M. Indian journal of nephrology. 2024; 34 (5) : 520-521.
Download PDF
Publication

Hubungan Dukungan Keluarga dengan Harga Diri Pada Pasien Kusta di Klinik Kulit dan Kelamin RSUD dr. Saiful Anwar Malang

Suhermin Y. Jurnal Keperawatan Muhammadiyah. 2024;
Download PDF
Publication

Diagnostic Enigma in a Rare Case of Primary Neuritic Leprosy

Ahmed S, Rahman A, Ahmed T, et al. Bangladesh Academy of Sciences. Bangladesh Journal of Medicine. 2024; 35 (3) : 214-217.
Download PDF
Publication

Profile of Leprosy Patients at the Dermatology and Venereology Polyclinic of Dr. M. Djamil Padang Hospital in 2018-2021

Habib El Binampiy Busnia , Gustia Rina , Deddy Herman . Asosiasi Penelitian dan Pengajar Ilmu Hukum Indonesia. International Journal of Health and Medicine. 2024; 1 (4) : 120-133.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 42
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD